Form 4: Select Medical Holdings Corp: Director Completes Merger Transaction
Statement of Changes in Beneficial Ownership
Marilyn B. Tavenner, a Director at Select Medical Holdings Corp., has reported the conversion of her common stock into cash following the company's merger.
Summary
- Marilyn B. Tavenner, a Director of Select Medical Holdings Corp., has filed a Form 4 reporting a transaction related to the company's merger.
- The transaction involved the conversion of her shares of common stock into cash as per the Agreement and Plan of Merger.
- Each share of common stock was converted into the right to receive $16.50 per share in cash, without interest.
- This also includes unvested restricted shares, which vested in full prior to the merger and were converted into the same cash consideration.
- The filing indicates that Tavenner beneficially owns 36,035 shares of common stock.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this filing as neutral, as it reports a standard post-merger transaction for an insider and does not provide new operational or financial performance data.
Positives
- The merger transaction has been completed, resulting in a cash payout for shareholders.
- All outstanding common stock, including restricted shares, was converted into cash, providing liquidity for the reporting person.
Negatives
- The filing does not detail any negative financial outcomes or operational challenges.
- The transaction represents a conversion of equity to cash, which may not be viewed as positive for long-term equity holders if the merger price is considered low.
Risks
- The filing does not explicitly mention any new risks or ongoing challenges.
- The primary risk associated with this type of transaction is the potential for the merger consideration to be undervalued by shareholders.
Future Outlook
The filing primarily reports on a completed merger transaction and does not contain forward-looking statements or guidance regarding future company performance.
Management Comments
- The filing is a standard SEC Form 4 reporting a transaction by a director, not a management commentary on company performance or strategy.
Industry Context
StockSavvy.ai notes that Form 4 filings are routine disclosures for insiders and this specific filing reflects the completion of a merger, a significant event that often leads to such equity-to-cash conversions for management and directors.
Stakeholder Impact
- Shareholders: Those who held common stock will receive $16.50 per share in cash, representing the culmination of their investment in Select Medical Holdings Corp. prior to the merger.
- Directors and Officers: Insiders like Marilyn B. Tavenner have converted their equity holdings into cash, realizing value from the merger.
Next Steps
- The merger transaction has been completed, with shares converted to cash.
- Further filings may occur to report any subsequent transactions by insiders.
Key Dates
| Date | Description |
|---|---|
| 03/02/2026 | Date of the Agreement and Plan of Merger. |
| 03/03/2026 | Date of Form 8-K filing detailing the Merger Agreement. |
| 06/30/2026 | Earliest transaction date reported in the Form 4, likely the effective date of the merger. |
| 07/01/2026 | Date of signature for the Form 4 filing. |
| 08/04/2025 | Date of execution for the Limited Power of Attorney. |
| 05/31/2026 | Expiration date of the notary commission for the Power of Attorney. |
Keywords
Select Medical Holdings Corp, SEM, Form 4, Merger, Marilyn B. Tavenner, Director, Beneficial Ownership, Common Stock, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.